The short version
Only one company currently supplies this market — there is no backup if it stumbles.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Sun Shield Broad Spectrum Spf 50 Matte Sunscreen
HOMOSALATE, OCTISALATE, and ZINC OXIDE · HOMOSALATE 100 mg/g; OCTISALATE 50 mg/g; ZINC OXIDE 165 mg/g · Lotion · Topical · Obagi Cosmeceuticals LLC
NDC 62032-0140-05 · 28 g in 1 TUBE · OTC MONOGRAPH DRUG · View full market →
Medicare Part D
Medicare Part D does not cover over-the-counter drugs — by law it pays only for products requiring a prescription.
How Part D pricing works →NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
Regulatory
- Application
- M020
- TE code
- —
- Approval date
- —
- Patents / exclusivity
- None on file
Shortage history
No FDA shortage reports for this drug or its presentations.
Recalls (this NDC)
No enforcement reports list this package NDC.
Manufacturers of HOMOSALATE, OCTISALATE, and ZINC OXIDE (Lotion)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Obagi Cosmeceuticals LLC | HOMOSALATE 100 mg/g; OCTISALATE 50 mg/g; ZINC OXIDE 165 mg/g | Jul 15, 2026 | Sep 2, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "Sun Shield Broad Spectrum Spf 50 Matte Sunscreen — NDC 62032-0140-05," retrieved September 3, 2026, https://drugdashboards.com/drug/62032014005.
Free to cite with attribution — see how the data is put together.